University of Exeter
Browse

Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study

Download (308.05 kB)
journal contribution
posted on 2025-07-30, 22:48 authored by PN Taylor, A Iqbal, C Minassian, A Sayers, MS Draman, R Greenwood, W Hamilton, O Okosieme, V Panicker, SL Thomas, Colin M. Dayan
Rates of thyroid hormone prescribing in the United States and the United Kingdom have increased substantially. If some of the increase is due to lowering the thyrotropin threshold for treatment, this may result in less benefit and greater harm.

Funding

Medical Research Council

History

Related Materials

  1. 1.
    ISSN - Is published in https://portal.issn.org/resource/ISSN/2168-6106
  2. 2.
    PMID - Is identical to https://pubmed.ncbi.nlm.nih.gov/24100714

Rights

Copyright 2014 American Medical Association

Notes

This is the author's post-print version of the article, which has been published in final form in JAMA Internal Medicine, and can be accessed via the DOI in this record.

External DOI

Journal

JAMA Internal Medicine

Publisher

American Medical Association

Place published

United States

Language

en

Citation

JAMA Internal Medicine, 2014, vol. 174, issue 1, pp. 32 - 39

Department

  • Archive

Usage metrics

    University of Exeter

    Categories

    No categories selected

    Keywords

    AgedCohort StudiesDrug TherapyFemaleGreat BritainHumansHypothyroidismMaleMiddle AgedOdds RatioRetrospective StudiesRisk AssessmentThyrotropinThyroxineTreatment Outcome

    Licence

    All rights reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC